Heavy silicone oil: A "novel" intraocular tamponade agent

Optometry and Vision Science

Volumn 88, Issue 6, 2011, Pages 772-775

  Cazabon, Sunildath ^a,c   Hillier, Roxane J ^b   Wong, David ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^c Health Park ^*  (United Kingdom)

Author keywords

Densiron; fundus; Heavy silicone oil; intraocular tamponade agent; proliferative vitreoretinopathy; retina; retinal detachment

Indexed keywords

DENSIRON; FUNDUS; HEAVY SILICONE OIL; INTRAOCULAR TAMPONADE AGENT; PROLIFERATIVE VITREORETINOPATHY; RETINA; RETINAL DETACHMENT;

DENSITY (SPECIFIC GRAVITY); SILICONES; SULFUR; SULFUR HEXAFLUORIDE; VISCOMETERS; VISCOSITY;

HEAVY WATER;

SILICONE OIL;

ARTICLE; CATARACT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; EYE DISEASE; HUMAN; INFLAMMATION; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR HYPERTENSION; PEROPERATIVE CARE; RECURRENT DISEASE; RELATIVE DENSITY; RETINA DETACHMENT; RETINA TEAR; VITREORETINAL SURGERY; VITREORETINOPATHY;

CATARACT; EYE DISEASES; HUMANS; INFLAMMATION; INJECTIONS, INTRAOCULAR; INTRAOPERATIVE CARE; OCULAR HYPERTENSION; RECURRENCE; RETINAL DETACHMENT; RETINAL PERFORATIONS; SILICONE OILS; SPECIFIC GRAVITY; VITREORETINAL SURGERY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 79958820854     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e318216d345     Document Type: Article

References (27)

1. Sharma T, Gopal L. Recent developments in vitreoretinal surgery. J Indian Med Assoc 2000;98:754-8; 760-2.
2. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987;103:38-43. (Pubitemid 17208965)
3. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988;106:668-74. (Pubitemid 19009920)
4. Spitznas M, Reiner J. A stereoscopic diagonal inverter (SDI) for wideangle vitreous surgery. Graefes Arch Clin Exp Ophthalmol 1987;225:9-12. (Pubitemid 17017845)
5. Spitznas M. A binocular indirect ophthalmomicroscope (BIOM) for non-contact wide-angle vitreous surgery. Graefes Arch Clin Exp Ophthalmol 1987;225:13-5. (Pubitemid 17017846)
6. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stalmans P. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-4. (Pubitemid 34240640)
7. Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC, Feron EJ, Stalmans P, Van Overdam K, Melles GR. Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003;110:2409-12. (Pubitemid 37485173)
8. Falkner CI, Binder S, Kruger A. Outcome after silicone oil removal. Br J Ophthalmol 2001;85:1324-7. (Pubitemid 33016113)
9. Scott IU, Flynn HW, Lai M, Chang S, Azen SP. First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 2000;130:745-50. (Pubitemid 32000855)
10. Scott IU, Flynn HW, Jr., Murray TG, Feuer WJ. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol 2003;136:454-63. (Pubitemid 37101242)
11. Fawcett IM, Williams RL, Wong D. Contact angles of substances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 1994;232:438-44. (Pubitemid 24193941)
12. Wetterqvist C, Wong D, Williams R, Stappler T, Herbert E, Freeburn S. Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 2004;88:692-6. (Pubitemid 38526655)
13. Winter M, Eberhardt W, Scholz C, Reichenbach A. Failure of potassium siphoning by Muller cells: a new hypothesis of perfluorocarbon liquidinduced retinopathy. Invest Ophthalmol Vis Sci 2000;41:256-61. (Pubitemid 30036575)
14. Kertes PJ, Wafapoor H, Peyman GA, Calixto N, Jr., Thompson H. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. Ophthalmology 1997;104:1159-65. (Pubitemid 27423860)
15. Bottoni F, Arpa P, Vinciguerra P, Zenoni S, De Molfetta V. Combined silicone and fluorosilicone oil tamponade (double filling) in the management of complicated retinal detachment. Ophthalmologica 1992;204:77-81.
16. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002;133:95-101. (Pubitemid 34076507)
17. Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN, Manousakis E, Herbert EN. A pilot study on the use of a perfluorohexyloctane/ silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005;89:662-5. (Pubitemid 40780568)
18. Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:900-6. (Pubitemid 24079820)
19. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995;79:953-60.
20. Asaria RH, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, Aylward GW, Charteris DG. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol 2004;88:1439-42. (Pubitemid 39424727)
21. Singh AK, Michels RG, Glaser BM. Scleral indentation following cryotherapy and repeat cryotherapy enhance release of viable retinal pigment epithelial cells. Retina 1986;6:176-8.
22. Singh AK, Glaser BM, Lemor M, Michels RG. Gravity-dependent distribution of retinal pigment epithelial cells dispersed into the vitreous cavity. Retina 1986;6:77-80. (Pubitemid 16009326)
23. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001;108:1179-83. (Pubitemid 32568123)
24. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT, Aylward GW. How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology 2001;108:1184-6. (Pubitemid 32568124)
25. Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 2004;111:2240-5. (Pubitemid 39575594)
26. Wiedemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 1998;126:550-9. (Pubitemid 28475919)
27. Wong D, Cazabon S, Ali H, Kumar I, Valldeperas X, Groenewald C, Pearce I. Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy? Ann Acad Med Singapore 2006;35:181-4.